Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Nerve Identification With Fluorescein Sodium
NCT06054178Phase 2Completed
- Sponsor
- Stanford University
- Start
- Nov 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorescein sodium 10% injection in pleomorphic adenoma (PA), Warthin tumor (WT), head and neck disorders (H&N), thyroid disease, sponsored by Stanford University. Started Nov 2024; status: completed.
02
Drugs
fluorescein sodium 10% injection
03
Conditions
pleomorphic adenoma (PA)Warthin tumor (WT)head and neck disorders (H&N)thyroid disease
Beyond the preview
Go deeper on NCT06054178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06054178.